Authors: Gluck, MR Moy, LY Jayatilleke, E Hogan, KA Manzino, L Sonsalla, PK

Citation: Mr. Gluck et al., Parallel increases in lipid and protein oxidative markers in several mousebrain regions after methamphetamine treatment, J NEUROCHEM, 79(1), 2001, pp. 152-160

Authors: Hogan, KA Lord, ST Okumura, N Terasawa, F Galankis, DK Scharrer, I Gorkun, OV

Citation: Ka. Hogan et al., A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV, THROMB HAEM, 83(4), 2000, pp. 592-597

Authors: Staal, RGW Hogan, KA Liang, CL German, DC Sonsalla, PK

Citation: Rgw. Staal et al., In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): Rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium, J PHARM EXP, 293(2), 2000, pp. 329-335

Authors: Hogan, KA Staal, RGW Sonsalla, PK

Citation: Ka. Hogan et al., Analysis of VMAT2 binding after methamphetamine or MPTP treatment: Disparity between homogenates and vesicle preparations, J NEUROCHEM, 74(5), 2000, pp. 2217-2220

Authors: Hogan, KA Gorkun, OV Lounes, KC Coates, AI Weisel, JW Hantgan, RR Lord, ST

Citation: Ka. Hogan et al., Recombinant fibrinogen Vlissingen/Frankfurt IV - The deletion of residues 319 and 320 from the gamma chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking and platelet aggregation, J BIOL CHEM, 275(23), 2000, pp. 17778-17785

Authors: White, PD Van Leeuwen, P Davis, BD Maddaloni, M Hogan, KA Marcus, AH Elias, RW

Citation: Pd. White et al., The conceptual structure of the integrated exposure uptake biokinetic model for lead in children, ENVIR H PER, 106, 1998, pp. 1513-1530